Local Ablation Therapy in Liver Cancer (Volume II)

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 62

Special Issue Editor


E-Mail Website
Guest Editor
School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea
Interests: hepatocellular carcinoma; hepatic metastasis; local ablation therapy; ultrasound; fusion imaging; radiofrequency ablation; microwave ablation; cryoablation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue is the second edition of the Special Issue titled “Local Ablation Therapy in Liver Cancer” (https://www.mdpi.com/journal/cancers/special_issues/7VG7J68Z3M).

Local ablation therapy, including radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation, has been widely used as a curative treatment option for early-stage hepatocellular carcinoma (HCC) or small metastatic colorectal cancer in the liver. Recently, MWA has been emerging in the field of local ablation therapy because it has better physical properties by providing faster and higher heat than RFA. RFA has seen continuous evolution in the past decade. Nowadays, centripetal RFA using multiple RF electrodes, even with the no-touch technique, is widely used for better local tumor control. Cryoablation is expected to produce comparable therapeutic outcomes to thermal ablation. Notably, cryoablation has been reported to have a lower complication rate in treating HCCs close to the bile duct or intrahepatic vessels than RFA. This Special Issue will present recent advances in local ablation therapy, including RFA, MWA, and cryoablation, in liver cancer.

Dr. Min Woo Lee
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • radiofrequency ablation
  • microwave ablation
  • cryoablation
  • hepatocellular carcinoma
  • metastasis

Published Papers

This special issue is now open for submission.
Back to TopTop